In accordance with the requirements of Regulation 30 and other applicable Regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015, Eris Lifesciences has informed that it enclosed the schedule of Analyst/ Institutional Investor Meetings held on Thursday, 24th June, 2021.
The above information is a part of company’s filings submitted to BSE.